CHICAGO–(BUSINESS WIRE)–April 11, 2022–Adtalem Global Education, Inc. (NYSE: ATGE), a leading healthcare educator, today announced the results of its takeover bid previously announced (the “Asset Sale Offering”)) of up to $373,333,000 of its 5.500% Senior Notes due 2028 (the “Notes”).
As of 5:00 p.m. ET on April 8, 2022 (the expiration date of the Notes), $373,333,000 principal amount of the Notes, representing 46.67% of the unpaid principal amount of the Notes, was validly tendered and accepted for purchase by Adtalem.
The Notes were offered in cash at a price equal to 100% of the principal amount of the Notes, being $1,000 per $1,000 principal amount of the Notes, plus accrued and unpaid interest and additional interest, if any , for such Notes up to , but not including April 11, 2022. The offer of sale of assets has been made pursuant to the indenture governing the Notes (as amended and supplemented, the “Indenture ”) and an offer to purchase and related letter of transmittal, each dated March 14, 2022.
This press release does not constitute a notice of redemption under the optional redemption provisions of the Indenture, nor an offer to sell or a solicitation of an offer to buy any securities. No offer, solicitation or sale will be made in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About Adtalem Global Education
Adtalem Global Education (NYSE: ATGE) is a leading healthcare educator and professional talent provider for the healthcare industry. With a focus on delivering strong outcomes that increase workforce readiness, Adtalem empowers a diverse population of learners to achieve their goals and make inspiring contributions to their communities. Adtalem is the parent organization of the American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. Adtalem and its institutions have over 10,000 employees and a network of over 275,000 alumni. Adtalem was named one of America’s Most Responsible Companies 2021 by Newsweek and one of America’s Best Diversity Employers 2021 by Forbes. Follow Adtalem on Twitter @adtalemglobal, LinkedIn or visit Adtalem.com for more information.
Certain statements in this release are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not relate report, which includes statements regarding future impacts of the COVID-19 pandemic, vaccine efficacy and delivery, and expected synergies from the recent acquisition of Walden. Forward-looking statements may also be identified by words such as “future”, “believe”, “expect”, “anticipate”, “estimate”, “plan”, “intend”, “may”. , “will”, “would”. ‘, ‘could’, ‘may’, ‘continue’, ‘preliminary’, ‘range’ and other similar terms. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include the risk factors described in Item 1A. “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC. These forward-looking statements are based on information available to us as of the date such statements are made, and we undertake no obligation to update any forward-looking statement except as required by law.